ASHLI KOVALICK: Open Payments
NPI 1912374174 · BELDEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$793 in 36 payments from 12 companies in 2025. Trend: 2023 $992 · 2024 $693 · 2025 $793
Food & beverage: $793
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 7 | $248 |
| Corcept Therapeutics | 5 | $85 |
| Insulet Corporation | 3 | $78 |
| Novo Nordisk Inc | 5 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| Abbott Laboratories | 2 | $46 |
| Xeris Pharmaceuticals, Inc. | 3 | $45 |
| Medtronic, Inc. | 1 | $43 |
| Lilly USA, LLC | 2 | $30 |
| SANOFI-AVENTIS U.S. LLC | 2 | $28 |
Products named: TWIIST, Korlym, Omnipod, JARDIANCE, Ozempic, FREESTYLE LIBRE, MINIMED 780G, MOUNJARO.
Industry payments across MS — which companies pay providers there.
